Reflect Study for ARCI-lamellar ichthyosis
A clinical trial for ichthyosis: Testing the safety and effectiveness of a topical cream for adults and adolescents living with ichthyosis.
The Reflect Study is testing the safety and effectiveness of a topical cream for adults and adolescents living with Lamellar Ichthyosis (LI). This investigational cream is applied to the surface of the skin in an effort to reduce LI symptoms such as dry and cracked skin. The Reflect
Study aims to help improve symptoms of LI for current and future generations.
Those Who Qualify For Study Participation Can Expect The Following:
Study Duration: 12 weeks, with the option to continue for another 12 weeks (up to 24 weeks)
Treatment Received: All study participants will randomly receive either the study medication with the active ingredient or placebo for the first 12 weeks (2/3 likelihood of receiving study medication with active ingredient). Those study participants who complete the first 12 weeks of the study and wish to continue for another 12 weeks will receive study medication with the active ingredient (no one will receive placebo).
Treatment Frequency: Twice weekly.
You May Qualify for the Reflect Study If You:
- Are 12 years of age or older
- Have been diagnosed with lamellar ichthyosis
- Have moderate to severe lamellar ichthyosis
See If You Qualify:
Additional study details, frequently asked questions, and contact information are available on the study website: IchthyosisStudy.com